Cargando…

Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2

Effective vaccine development for global outbreaks, such as the coronavirus disease 2019 (COVID-19), has been successful in the short run. However, the currently available vaccines have been associated with a higher frequency of adverse effects compared with other general vaccines. In this study, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Wonsuck, Park, Yongsung, Kim, Seunghyun, Bang, Iel Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777945/ https://www.ncbi.nlm.nih.gov/pubmed/35062728 http://dx.doi.org/10.3390/vaccines10010067

Ejemplares similares

Combined Therapy with microRNA-Expressing Salmonella and Irradiation in Melanoma
por: Yoon, Wonsuck, et al.
Publicado: (2021)

Bacterially Delivered miRNA-Mediated Toll-like Receptor 8 Gene Silencing for Combined Therapy in a Murine Model of Atopic Dermatitis: Therapeutic Effect of miRTLR8 in AD
por: Yoon, Wonsuck, et al.
Publicado: (2021)

Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
por: Wang, Chao, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 in a rural Ugandan population
por: Mugisha, Joseph, et al.
Publicado: (2023)

Enhancement of Host Immune Responses by Oral Vaccination to Salmonella enterica serovar Typhimurium Harboring Both FliC and FljB Flagella
por: Eom, Jeong Seon, et al.
Publicado: (2013)

The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
por: Isitt, Catherine, et al.
Publicado: (2022)

Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Cationic Surfactants as Disinfectants against SARS-CoV-2
por: Karamov, Eduard V., et al.
Publicado: (2022)

Platforms Exploited for SARS-CoV-2 Vaccine Development
por: Mathew, Shilu, et al.
Publicado: (2020)

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

Controversies and Challenges of Mass Vaccination against SARS-CoV-2 in Italy: Medico-Legal Perspectives and Considerations
por: Barranco, Rosario, et al.
Publicado: (2021)

First case of postmortem study in a patient vaccinated against SARS-CoV-2
por: Hansen, Torsten, et al.
Publicado: (2021)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
por: Sugiyama, Kazuo, et al.
Publicado: (2022)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Inducible spy Transcription Acts as a Sensor for Envelope Stress of Salmonella typhimurium
por: Jeong, Seon Mi, et al.
Publicado: (2017)

Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay
por: Hong, Ki Ho, et al.
Publicado: (2022)

Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated Salmonella typhimurium as a Carrier in Rat
por: Zhu, Dan, et al.
Publicado: (2022)

Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2
por: Hemmati, Farshad, et al.
Publicado: (2021)

Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2
por: Seephetdee, Chotiwat, et al.
Publicado: (2021)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Mendonça, Samir Andrade, et al.
Publicado: (2021)

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
por: King, William W., et al.
Publicado: (2021)

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
por: Zhong, Chaojie, et al.
Publicado: (2021)

Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: A case report
por: Lazaro, Luciana G., et al.
Publicado: (2022)

Alterations in Laboratory Parameters Related to Disease Severity in Vaccinated Patients Against SARS-CoV-2
por: Lagadinou, Maria, et al.
Publicado: (2022)

Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers
por: Kim, Yu-Kyung, et al.
Publicado: (2022)

Lectin Analysis of SARS-CoV-2-Positive Nasopharyngeal Samples Using GLYcoPROFILE(®) Technology Platform
por: Seničar, Mateja, et al.
Publicado: (2022)

The Alterations of Serum N-glycome in Response to SARS-CoV-2 Vaccination
por: Dojcsák, Dalma, et al.
Publicado: (2023)

Correlation of SARS-CoV-2 Neutralization with Antibody Levels in Vaccinated Individuals
por: Chowdhury, Shazeda Haque, et al.
Publicado: (2023)

SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
por: Ahmed, Syed Faraz, et al.
Publicado: (2022)

Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case–Control Study
por: Alkadi, Mohamad M., et al.
Publicado: (2022)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2
por: Park, Kyong-Su, et al.
Publicado: (2023)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2
por: Cerino, Pellegrino, et al.
Publicado: (2021)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers
por: Sansone, Emanuele, et al.
Publicado: (2021)

Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
por: Hiroi, Satoshi, et al.
Publicado: (2023)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csuvbln248r05b1qdg466acbr8